ZA92664B - Compositions and method for soft tissue tumors. - Google Patents

Compositions and method for soft tissue tumors.

Info

Publication number
ZA92664B
ZA92664B ZA92664A ZA92664A ZA92664B ZA 92664 B ZA92664 B ZA 92664B ZA 92664 A ZA92664 A ZA 92664A ZA 92664 A ZA92664 A ZA 92664A ZA 92664 B ZA92664 B ZA 92664B
Authority
ZA
South Africa
Prior art keywords
compositions
soft tissue
tissue tumors
tumors
phenoliccarboxylate
Prior art date
Application number
ZA92664A
Other languages
English (en)
Inventor
David A Wilson
R Keith Frank
Joseph R Garlich
Jaime Simon
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of ZA92664B publication Critical patent/ZA92664B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Stringed Musical Instruments (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA92664A 1991-01-30 1992-01-30 Compositions and method for soft tissue tumors. ZA92664B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/648,493 US5342925A (en) 1991-01-30 1991-01-30 Radioactive compositions for soft tissue tumors

Publications (1)

Publication Number Publication Date
ZA92664B true ZA92664B (en) 1993-07-30

Family

ID=24601013

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92664A ZA92664B (en) 1991-01-30 1992-01-30 Compositions and method for soft tissue tumors.

Country Status (18)

Country Link
US (1) US5342925A (xx)
EP (1) EP0497356B1 (xx)
JP (1) JP3300348B2 (xx)
KR (1) KR100256456B1 (xx)
AT (1) ATE169615T1 (xx)
AU (1) AU654169B2 (xx)
CA (1) CA2060330C (xx)
DE (1) DE69226541T2 (xx)
DK (1) DK0497356T3 (xx)
ES (1) ES2118758T3 (xx)
FI (1) FI924362A0 (xx)
IE (1) IE920310A1 (xx)
IL (1) IL100801A (xx)
MX (1) MX9200414A (xx)
NZ (1) NZ241464A (xx)
TW (1) TW215091B (xx)
WO (1) WO1992013826A1 (xx)
ZA (1) ZA92664B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670456B2 (en) * 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US421452A (en) * 1890-02-18 Island
GB718509A (en) * 1950-06-16 1954-11-17 Ciba Ltd Manufacture of new imino-dicarboxylic acids and functional derivatives thereof
US3132934A (en) * 1958-08-08 1964-05-12 Ciba Ltd Ferric chelates of 1-hyroxy-2:6-di-[(n, n1-bis-carboxy-ethyl or methyl)-amino-methyl] benzenes
CH393356A (de) * 1958-08-08 1965-06-15 Ciba Geigy Verfahren zur Herstellung neuer Eisen-Komplexsalze
US4091088A (en) * 1975-02-19 1978-05-23 Australian Atomic Energy Commission Phenolic amino-carboxylic acid complexes for forming radiopharmaceuticals
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
USRE31463E (en) * 1975-03-03 1983-12-13 Research Corporation Radiopharmaceutical chelates and method of external imaging
CH607920A5 (xx) * 1976-05-31 1978-12-15 Solco Basel Ag
DE2920174A1 (de) * 1979-05-18 1980-11-20 Hoechst Ag Technetium-99m-markierte acetanilidoiminodiacetate zur leberfunktionsdiagnostik
US4308249A (en) * 1979-12-13 1981-12-29 G. D. Searle & Co. Radiopharmaceutical complexes of N-(tri-substituted alkyl)-iminodiacetic acids
JPS5791927A (en) * 1980-11-27 1982-06-08 Nippon Mejifuijitsukusu Kk Technetium-99m labelled diagnosticum
US4418208A (en) * 1980-12-29 1983-11-29 E. R. Squibb & Sons, Inc. N-Substituted iminodiacetic acids
US4801722A (en) * 1981-07-01 1989-01-31 Eastman Kodak Company Coumarin chelates
US4637988A (en) * 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
US4454107A (en) * 1982-08-30 1984-06-12 Merck & Co., Inc. Tc99m-Phenida, radioscintigraphic agent for diagnosis of hepatoniliary disease
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
US4909257A (en) * 1986-05-01 1990-03-20 The Regents Of The University Of California Method for attaining in vivo tissue-specific contrast by nuclear magnetic resonance imaging
WO1989006980A1 (en) * 1988-01-29 1989-08-10 University Of Queensland Radiopharmaceuticals
NZ231180A (en) * 1988-10-31 1994-11-25 Dow Chemical Co Bifunctional chelants;complexes,conjugates and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
DE69226541D1 (de) 1998-09-17
IL100801A (en) 1996-11-14
WO1992013826A1 (en) 1992-08-20
AU654169B2 (en) 1994-10-27
DE69226541T2 (de) 1998-12-24
IE920310A1 (en) 1992-07-29
EP0497356A1 (en) 1992-08-05
ATE169615T1 (de) 1998-08-15
AU1054492A (en) 1992-08-06
KR930700162A (ko) 1993-03-13
ES2118758T3 (es) 1998-10-01
FI924362A (fi) 1992-09-29
JP3300348B2 (ja) 2002-07-08
MX9200414A (es) 1992-07-01
KR100256456B1 (ko) 2000-08-01
CA2060330C (en) 2002-11-26
CA2060330A1 (en) 1992-07-31
JPH05505627A (ja) 1993-08-19
EP0497356B1 (en) 1998-08-12
IL100801A0 (en) 1992-09-06
NZ241464A (en) 1994-11-25
US5342925A (en) 1994-08-30
FI924362A0 (fi) 1992-09-29
TW215091B (xx) 1993-10-21
DK0497356T3 (da) 1999-05-17

Similar Documents

Publication Publication Date Title
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
EP0350230A3 (en) Immunoconjugates for cancer diagnosis and therapy
AU1000488A (en) A light ray radiation device for use in medical treatment of the nose and throat passages
EP0378692A4 (en) Catheter for medical treatment
SG45366A1 (en) Method of treating and/or diagonising soft tissue tumors
AU581850B2 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
SG44640A1 (en) Chelants possessing ortho ligating functionality and complexes thereof
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
ZA92664B (en) Compositions and method for soft tissue tumors.
WO1997005904A3 (de) Verwendung von metall-clustern als kontrastmittel oder strahlentherapeutikum
EP0471790A4 (en) Method for localization and treatment of tumors and complexes therefor
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
AU5423490A (en) Improved method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition
HU9202444D0 (en) Method for producing medical preparatives containing anaesthetic and applicqble for iontophoretic treatment
IL99982A0 (en) Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions
AU5426490A (en) Method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition
JPS55136069A (en) Linear particle accelerator for medical treatment
GR3006404T3 (xx)
IE893615L (en) Use of edta in medical treatment
GB9007763D0 (en) Method and composition for the treatment of cancer
UA9981A (uk) Спосіб лікування хворих з переломами трубчастих кісток
AU7231191A (en) Compounds and methods for the treatment and diagnosis of cancer